AAAAAA
Results:
1-11
|
Results: 11
Authors:
Vehkavaara, S
Silveira, A
Hakala-Ala-Pietila, T
Virkamaki, A
Hovatta, O
Hamsten, A
Taskinen, MR
Yki-Jarvinen, H
Citation: S. Vehkavaara et al., Effects of oral and transdermal estrogen replacement therapy on markers ofcoagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women, THROMB HAEM, 85(4), 2001, pp. 619-625
Authors:
Virkamaki, A
Korsheninnikova, E
Seppala-Lindroos, A
Vehkavaara, S
Goto, T
Halavaara, J
Hakkinen, AM
Yki-Jarvinen, H
Citation: A. Virkamaki et al., Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle, DIABETES, 50(10), 2001, pp. 2337-2343
Authors:
Zisman, A
Peroni, OD
Abel, ED
Michael, MD
Mauvais-Jarvis, F
Lowell, BB
Wojtaszewski, JFP
Hirshman, MF
Virkamaki, A
Goodyear, LJ
Kahn, CR
Kahn, BB
Citation: A. Zisman et al., Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance, NAT MED, 6(8), 2000, pp. 924-928
Authors:
Vehkavaara, S
Westerbacka, J
Hakala-Ala-Pietila, T
Virkamaki, A
Hovatta, O
Yki-Jarvinen, H
Citation: S. Vehkavaara et al., Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women, J CLIN END, 85(12), 2000, pp. 4663-4670
Authors:
Mauvais-Jarvis, F
Virkamaki, A
Michael, MD
Winnay, JN
Zisman, A
Kulkarni, RN
Kahn, CR
Citation: F. Mauvais-jarvis et al., A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes, DIABETES, 49(12), 2000, pp. 2126-2134
Authors:
Vehkavaara, S
Hakala-Ala-Pietila, T
Virkamaki, A
Bergholm, R
Ehnholm, C
Hovatta, O
Taskinen, MR
Yki-Jarvinen, H
Citation: S. Vehkavaara et al., Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women, CIRCULATION, 102(22), 2000, pp. 2687-2693
Authors:
Yki-Jarvinen, H
Nyman, T
Rissanen, E
Leino, M
Hamalainen, S
Virkamaki, A
Hauguel-de Mouzon, S
Citation: H. Yki-jarvinen et al., Glutamine: Fructose-6-phosphate amidotransferase activity and gene expression are regulated in a tissue-specific fashion in pregnant rats, LIFE SCI, 65(2), 1999, pp. 215-223
Authors:
Virkamaki, A
Ueki, K
Kahn, CR
Citation: A. Virkamaki et al., Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance, J CLIN INV, 103(7), 1999, pp. 931-943
Authors:
Makimattila, S
Luoma, JS
Yla-Herttuala, S
Bergholm, R
Utriainen, T
Virkamaki, A
Mantysaari, M
Summanen, P
Yki-Jarvinen, H
Citation: S. Makimattila et al., Autoantibodies against oxidized LDL and endothelium-dependent vasodilationin insulin-dependent diabetes mellitus, ATHEROSCLER, 147(1), 1999, pp. 115-122
Authors:
Patti, ME
Virkamaki, A
Landaker, EJ
Kahn, CR
Yki-Jarvinen, H
Citation: Me. Patti et al., Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle, DIABETES, 48(8), 1999, pp. 1562-1571
Authors:
Virkamaki, A
Yki-Jarvinen, H
Citation: A. Virkamaki et H. Yki-jarvinen, Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscleand heart, DIABETES, 48(5), 1999, pp. 1101-1107
Risultati:
1-11
|